Vicore Pharma Holding AB (publ) logo

Vicore Pharma Holding AB (publ)

SSE:VICO.ST

Overview | Financials
Company Name Vicore Pharma Holding AB (publ)
Symbol VICO.ST
Currency SEK
Price 14.38
Market Cap 1,606,576,740
Dividend Yield 0%
52-week-range 12.36 - 26.9
Industry Biotechnology
Sector Healthcare
CEO Mr. Ahmed S. Mousa J.D.
Website https://www.vicorepharma.com

An error occurred while fetching data.

About Vicore Pharma Holding AB (publ)

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis

Related Stocks

RaySearch Laboratories AB (publ) logo

RaySearch Laboratories AB (publ)

RAY-B.ST

92.2 SEK

Intervacc AB (publ) logo

Intervacc AB (publ)

IVACC.ST

3.735 SEK

IRLAB Therapeutics AB (publ) logo

IRLAB Therapeutics AB (publ)

IRLAB-A.ST

14.45 SEK

Doxa AB (publ) logo

Doxa AB (publ)

DOXA.ST

3.2 SEK

Elos Medtech AB (publ) logo

Elos Medtech AB (publ)

ELOS-B.ST

203 SEK

Humana AB (publ) logo

Humana AB (publ)

HUM.ST

27 SEK

Mentice AB (publ) logo

Mentice AB (publ)

MNTC.ST

34.4 SEK

Xbrane Biopharma AB (publ) logo

Xbrane Biopharma AB (publ)

XBRANE.ST

2.085 SEK

Q-linea AB (publ) logo

Q-linea AB (publ)

QLINEA.ST

2.49 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD